Oxaliplatin, gemcitabine, and erlotinib study in patients with advanced chemo-naive pancreatic cancer

Trial Profile

Oxaliplatin, gemcitabine, and erlotinib study in patients with advanced chemo-naive pancreatic cancer

Discontinued
Phase of Trial: Phase II

Latest Information Update: 19 Jan 2014

At a glance

  • Drugs Gemcitabine (Primary) ; Oxaliplatin (Primary) ; Erlotinib
  • Indications Pancreatic cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 Jan 2014 According to ClinicalTrials.gov record, Status changed from recruiting to discontinued.
    • 27 Mar 2011 Planned End Date changed from 1 Jan 2010 to 1 Dec 2011 as reported by ClinicalTrials.gov.
    • 07 Apr 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top